Literature DB >> 1081287

Evidence that monoamines influence human evoked potentials.

E W Schafer, C M McKean.   

Abstract

We have measured latency and flash/pattern differentials of the visual evoked potential (VEP) from phenylketonuric humans, while systematically manipulating rates of amine synthesis in the central nervous system using two techniques. We have observed that stimulation of monoaminergic activity in the visual processing system, either by lowering inhibitory levels of phenylalanine through dietary restriction or by a properly balanced administration of indole and catecholamine precursors, shortened VEP latencies and permitted the development of a discriminative brain response to patterned stimuli. The close temporal relationship between these electrophysiological changes and the neurochemical manipulations following treatment initiation of discontinuation argue that monoamines play a significant role in the mediation of human sensory evoked potentials.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1081287     DOI: 10.1016/0006-8993(75)90607-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Long term decline of P100 amplitude in migraine with aura.

Authors:  N M Khalil; N J Legg; D J Anderson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-10       Impact factor: 10.154

2.  Brief report: an open middle-term study of combined vitamin B6-magnesium in a subgroup of autistic children selected on their sensitivity to this treatment.

Authors:  J Martineau; C Barthelemy; C Cheliakine; G Lelord
Journal:  J Autism Dev Disord       Date:  1988-09

3.  Visual evoked responses in chronic alcoholics.

Authors:  Y W Chan; J G McLeod; R R Tuck; J C Walsh; P A Feary
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-08       Impact factor: 10.154

Review 4.  Efficacy of vitamin B6 and magnesium in the treatment of autism: a methodology review and summary of outcomes.

Authors:  S I Pfeiffer; J Norton; L Nelson; S Shott
Journal:  J Autism Dev Disord       Date:  1995-10

5.  Visual and auditory evoked responses in patients with Parkinson's disease.

Authors:  M J Gawel; P Das; S Vincent; F C Rose
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-03       Impact factor: 10.154

6.  Evaluation of the visual system with visual evoked potential and optical coherence tomography in patients with idiopathic Parkinson's disease and with multiple system atrophy.

Authors:  Melike Batum; Ayşın Kısabay Ak; Mehmet Semih Arı; Hüseyin Mayali; Emin Kurt; Deniz Selçuki
Journal:  Doc Ophthalmol       Date:  2022-07-26       Impact factor: 1.854

7.  Migraine patients exhibit abnormalities in the visual evoked potential.

Authors:  J F Connolly; M Gawel; F C Rose
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-05       Impact factor: 10.154

8.  Pattern-reversal visual evoked potentials in phenylketonuric children.

Authors:  A Landi; A Ducati; R Villani; R Longhi; E Riva; C Rodocanachi; M Giovannini
Journal:  Childs Nerv Syst       Date:  1987       Impact factor: 1.475

9.  Effects of carbamazepine and valproate on brainstem auditory evoked potentials in epileptic children.

Authors:  A Yuksel; D Senocak; D Sozuer; G Keskin; A Dirican; A Cenani; E Yalcin
Journal:  Childs Nerv Syst       Date:  1995-08       Impact factor: 1.475

10.  Visual evoked potentials in phenylketonuria: association with brain MRI, dietary state, and IQ.

Authors:  S J Jones; G Turano; A Kriss; F Shawkat; B Kendall; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-09       Impact factor: 10.154

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.